SOPHiA GENETICS SA - Ordinary Shares (NQ:SOPH)

6.730 -0.560 (-7.68%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SOPHiA GENETICS SA - Ordinary Shares

< Previous 1 2 3 4 Next >

Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

October 08, 2026

From Myriad Genetics, Inc.

Via GlobeNewswire

When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals ↗

August 27, 2026

Canada Goose, Capital Clean Energy Carriers and SOPHiA Genetics have each seen unusual trading volume recently, driven by tariffs, LNG demand, and a strong earnings beat, respectively.

Via MarketBeat

Topics Earnings World Trade

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Revenue jumped 27% as platform volume surged and biopharma partnerships accelerated.

Via The Motley Fool

Topics Artificial Intelligence Earnings

SOPHiA GENETICS (NASDAQ:SOPH) Beats Q2 Revenue Estimates, Shares Rise Despite Wider Loss ↗

August 04, 2026

Via Chartmill

SOPHiA GENETICS (NASDAQ:SOPH) Q1 Revenue Beats Estimates but Earnings Miss Sparks Pre-Market Decline ↗

May 05, 2026

Via Chartmill

Topics Earnings

SOPHiA GENETICS Q2 Earnings Call Highlights ↗

August 04, 2026

SOPHiA GENETICS (NASDAQ:SOPH) reported second-quarter revenue growth of 27% and raised its full-year revenue outlook, as the precision medicine software company cited accelerating U.S. adoption, liquid...

Via MarketBeat

Topics Earnings

SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript ↗

May 05, 2026

SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript ↗

March 03, 2026

SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript

Via The Motley Fool

SOPHiA GENETICS SA (NASDAQ:SOPH) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss ↗

March 03, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Exploring Sophia Genetics's Earnings Expectations ↗

November 04, 2024

Via Benzinga

Zscaler To Rally More Than 9%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 10, 2025

Via Benzinga

SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2025 Earnings: Revenue Beat and Raised Guidance Fuel Pre-Market Rally ↗

November 04, 2025

SOPHiA GENETICS Q3 2025 results beat revenue estimates and the company raised its full-year 2025 outlook, driving positive investor sentiment.

Via Chartmill

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

November 03, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores ↗

October 03, 2025

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

Via Benzinga

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

SOPHiA GENETICS SA (NASDAQ:SOPH) Beats Q2 2025 Earnings Estimates, Shares Jump in Pre-Market Trading ↗

August 05, 2025

SOPHiA GENETICS beats Q2 2025 estimates with $18.32M revenue and $0.33 EPS, driving shares up 5.45% in pre-market trading.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 17, 2025

Via Benzinga

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

September 23, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 15, 2025

Via Benzinga

SOPH Stock Earnings: Sophia Genetics Beats EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

June 24, 2024

Shareholders adopt all proposals at Annual General Meeting

From SOPHiA GENETICS, Inc.

Via GlobeNewswire

Why Nvidia Stock Investors Should Be Excited About an Upcoming IPO ↗

May 30, 2024

CoreWeave, a company backed by Nvidia, is preparing to go public in 2025.

Via The Motley Fool

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 29, 2024

Via Benzinga

Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday ↗

May 29, 2024

Via Benzinga

SOPH Stock Earnings: Sophia Genetics Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

SOPHiA GENETICS Reports First Quarter 2024 Results

May 07, 2024

Consistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed

From SOPHiA GENETICS, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.